Volgen
adina popa
adina popa
Geverifieerd e-mailadres voor umfcluj.ro
Titel
Geciteerd door
Geciteerd door
Jaar
An overview of healthcare associated infections and their detection methods caused by pathogen bacteria in Romania and Europe
S Szabó, B Feier, D Capatina, M Tertis, C Cristea, A Popa
Journal of clinical medicine 11 (11), 3204, 2022
392022
Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers
L Vlase, M Neag, A Popa, D Muntean, I Bâldea, SE Leucuta
Journal of Clinical Pharmacy and Therapeutics 36 (2), 225-229, 2011
392011
Potentially inappropriate medications in elderly ambulatory and institutionalized patients: an observational study
DP Primejdie, MT Bojita, A Popa
BMC Pharmacology and Toxicology 17, 1-10, 2016
372016
A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers
C Briciu, M Neag, D Muntean, L Vlase, C Bocsan, A Buzoianu, ...
Journal of clinical pharmacy and therapeutics 39 (5), 535-540, 2014
362014
Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers
L Vlase, A Popa, M Neag, D Muntean, I Bâldea, SE Leucuta
The Journal of Clinical Pharmacology 51 (8), 1233-1236, 2011
302011
Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers
L Vlase, A Popa, M Neag, D Muntean, SE Leucuţa
European journal of drug metabolism and pharmacokinetics 35, 83-87, 2011
302011
Pharmacokinetic interaction between ivabradine and phenytoin in healthy subjects
L Vlase, A Popa, M Neag, D Muntean, SE Leucuta
Clinical drug investigation 32, 533-538, 2012
262012
Evaluation of a potential metabolism-mediated drug-drug interaction between atomoxetine and bupropion in healthy volunteers
I Todor, A Popa, M Neag, D Muntean, C Bocsan, A Buzoianu, L Vlase, ...
Journal of Pharmacy & Pharmaceutical Sciences 19 (2), 198-207, 2016
242016
Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteers
C Briciu, M Neag, D Muntean, C Bocsan, A Buzoianu, O Antonescu, ...
Clujul Medical 88 (2), 208, 2015
242015
Assessment of a potential pharmacokinetic interaction between nebivolol and bupropion in healthy volunteers
AM Gheldiu, A Popa, M Neag, D Muntean, C Bocsan, A Buzoianu, L Vlase, ...
Pharmacology 98 (3-4), 190-198, 2016
222016
Evaluation of restricted antibiotic use in a hospital in Romania
P Tarcea Bizo, D Dumitras, A Popa
International journal of clinical pharmacy 37, 452-456, 2015
222015
Validation of HPLC-UV method for analysis of omeprazole in presence of its metabolites in human plasma
C Iuga, M Moldovan, A Popa, SE Leucuta
FARMACIA-BUCURESTI- 56 (3), 254, 2008
182008
E-Financial reporting within the Romanian public sector governance
AT Tudor, R Blidisel, A Popa
Conference on e-Government at Westminster Business School University of …, 2009
152009
Evaluation of the potential pharmacokinetic interaction between atomoxetine and fluvoxamine in healthy volunteers
I Todor, A Popa, M Neag, D Muntean, C Bocsan, A Buzoianu, L Vlase, ...
Pharmacology 99 (1-2), 84-88, 2017
132017
Effect of fluvoxamine on the pharmokinetics of zolpidem: A two‐treatment period study in healthy volunteers
L Vlase, A Popa, M Neag, D Muntean, M Achim, SE Leucuţa
Clinical and Experimental Pharmacology and Physiology 39 (1), 9-12, 2012
132012
Effect of fluoxetine on the pharmacokinetics of lansoprazole: a two-treatment period study in healthy male subjects
L Vlase, A Popa, M Neag, D Muntean, SE Leucuta
Clinical Drug Investigation 31, 727-733, 2011
122011
Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers
L Vlase, A Popa, D Muntean, SE Leucuta
Arzneimittelforschung 60 (09), 560-563, 2010
122010
Pharmaceutical care and pharmacy education in Romania
A Popa, O Crisan, R Sandulescu, M Bojita
Pharmacy Education 2 (1), 11-14, 2002
122002
Pharmacokinetic interaction between fluoxetine and omeprazole in healthy male volunteers: a prospective pilot study
L Vlase, M Neag, A Popa, D Muntean, SE Leucuta
Current therapeutic research 71 (6), 360-368, 2010
112010
Linezolid administration to critically ill patients: intermittent or continuous infusion? A systematic literature search and review
LA Hui, C Bodolea, L Vlase, EI Hiriscau, A Popa
Antibiotics 11 (4), 436, 2022
102022
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20